{"filing":{"accession_number":"0001641489-26-000024","cik":"0001641489","ticker":"VTVT","company_name":"vTv Therapeutics Inc.","form":"8-K","filing_date":"2026-06-29","report_date":null,"primary_document":"vtvt-20260626.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1641489/000164148926000024/vtvt-20260626.htm"},"events":[{"id":14642,"run_id":13044,"accession_number":"0001641489-26-000024","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from vTv Therapeutics' 2026 Annual Meeting of Stockholders held on June 26, 2026. The filing reports voting outcomes on three matters: (1) election of seven director nominees to the Board, (2) ratification of Ernst \u0026 Young LLP as independent auditor, and (3) nonbinding advisory vote on named executive officer compensation. This is a textbook Item 5.07 disclosure and is material to investors as it reflects governance decisions and board composition.","company_name":"vTv Therapeutics Inc.","ticker":"VTVT","filing_date":"2026-06-29","form":"8-K","submitted_at":null,"items":[{"id":12126,"accession_number":"0001641489-26-000024","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from vTv Therapeutics' 2026 Annual Meeting of Stockholders held on June 26, 2026. The filing reports voting outcomes on three matters: (1) election of seven director nominees to the Board, (2) ratification of Ernst \u0026 Young LLP as independent auditor, and (3) nonbinding advisory vote on named executive officer compensation. This is a textbook Item 5.07 disclosure and is material to investors as it reflects governance decisions and board composition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:15:36.610915+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12126,"accession_number":"0001641489-26-000024","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from vTv Therapeutics' 2026 Annual Meeting of Stockholders held on June 26, 2026. The filing reports voting outcomes on three matters: (1) election of seven director nominees to the Board, (2) ratification of Ernst \u0026 Young LLP as independent auditor, and (3) nonbinding advisory vote on named executive officer compensation. This is a textbook Item 5.07 disclosure and is material to investors as it reflects governance decisions and board composition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-29T20:15:36.610915+00:00","company_name":"vTv Therapeutics Inc.","ticker":"VTVT","filing_date":"2026-06-29"}]}